Please login to the form below

Not currently logged in
Email:
Password:

Depomed

This page shows the latest Depomed news and features for those working in and with pharma, biotech and healthcare.

Horizon swoops on Raptor to add rare disease products

Horizon swoops on Raptor to add rare disease products

The deal is Horizon's second acquisition this year after losing out on an earlier $3bn bid to buy specialty drugmaker Depomed.

Latest news

More from news
Approximately 3 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Licence collaboration agreement. 1, 110. Janssen/ Depomed. Nucynta [tapentadol] franchise including extended release tablets and oral solutions.

  • Pharma deals during January 2015 Pharma deals during January 2015

    Asset swaps and divestments were a strong feature during 2014 and J&J has followed suit with the divestment to Depomed of the US rights to its Nucynta franchise (tapentadol for

  • Deal Watch table for October 2013 Deal Watch table for October 2013

    275. Depomed / PDL Pharma. Royalty and milestone monetisation. Licence agreements in the type 2 diabetes therapeutic area.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Ron Menezes joins Almirall’s Aqua Pharmaceuticals Ron Menezes joins Almirall’s Aqua Pharmaceuticals

    Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS. ... Prior to his role at Depomed, Menezes was at Allergan in senior roles including vice president sales and marketing,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics